Staccato Loxapine Thorough QT/QTc Study

Completed · Phase 1 · Has a placebo group

Conditions studied: Thorough QT/QTc Study

In brief

The purpose of the present Phase 1 study was to assess the cardiac safety of Staccato Loxapine administered to healthy volunteers in a 3 period crossover study.

Key facts

Study ID

NCT00874237

Run by

Nova Pneuma Inc.

People needed

48

Starts

2009-04-01

Expected to finish

2009-06-01

Last updated by the study team

2026-04-22

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects who are in good general health and agree to use a medically acceptable and effective birth control method throughout the study.

You may not qualify if…

• Subjects who have taken prescription or nonprescription medication within 5 days of treatment,
• Subjects who have had an acute illness within the last 5 days of treatment,
• Subjects who are smokers, OR
• Subjects who have an ECG abnormality at baseline.

Where it is running

• Covance Clinical Research Unit Inc. — Evansville, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.